Skip to main content
SpringerLink
Log in

Ceftriaxone cost effective in patients with acute stroke

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2014 euros

Reference

  • Westendorp WF, et al. Preventive Antibiotics in Stroke Study (PASS): A cost-effectiveness study. Neurology : 6 Apr 2018

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ceftriaxone cost effective in patients with acute stroke. PharmacoEcon Outcomes News 801, 7 (2018). https://doi.org/10.1007/s40274-018-4862-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4862-x

Search

Navigation